Table 2.
CPI-613 dose and infusion rate
| CPI-613 dose per time interval | n | mg | m/kg | mg/m2 |
|---|---|---|---|---|
| First dose | 33 | 3975.0 (1842.2), 4300.0 | 50.6 (21.5), 58.4 | 2071.1 (880.9), 2311.6 |
| First 5 doses | 27 | 19,013.0 (9622.8), 21,250.0 | 240.2 (109.1), 291.1 | 9811.6 (4549.2), 11,494.3 |
| First 4 weeks | 26 | 26,107.6 (12,887.4), 27400.0 | 326.6 (147.8), 364.6 | 13,370.8 (6107.7), 14,845.4 |
| Weeks 5 through 15 | 21 | 49,550.0 (28,354.9), 49550.0 | 538.5 (306.6), 537.7 | 21,770.0 (11,888.9), 22,988.5 |
| Weeks 16 through 24 | 9 | 44,988.9 (30,160.3), 29000.0 | 573.9 (456.1), 385.7 | 23,427.8 (17,804.5), 15,025.9 |
| Weeks 25 through 36 | 2 | 101,250.0 (8273.2), 101250.0 | 1442.9 (230.8), 1442.9 | 57,307.3 (6506.6), 57,307.3 |
| Weeks 37 through 48 | 2 | 83,000.0 (12,445.1), 83000.0 | 1186.0 (269.6), 1186.0 | 47,029.0 (8534.1), 47,029.0 |
| Weeks 49 through 72 | 1 | 202,500.0 | 3036.8 | 117,052.0 |
| Weeks 73 through 96 | 1 | 76,800.0 | 1151.7 | 44,393.1 |
| CPI-613 infusion rate | n | mg × min−1 | m/kg × min−1 | mg/m2 × min−1 |
| First dose | 33 | 33.1 (15.4), 35.8 | 0.4 (0.2), 0.5 | 17.2 (8.0), 19.2 |
| First 5 doses | 27 | 158.4 (80.2), 177.1 | 2.0 (0.9), 2.4 | 81.8 (37.9), 95.8 |
Data presented as mean (SD), median. n, number of patients.